Diabetic Foot Infections

SAN FRANCISCO — Results showed use of local antibiotic-loaded hydroxyapatite and calcium sulfate biocomposite void filler may increase limb salvage and ulcer healing rates among patients with diabetic foot infections and vascular disease.

Two separate analyses of studies and trials suggest that COVID-19 rebound is not linked to Paxlovid or other antiviral drugs.

Clinicians and microbiologists who care for patients with diabetic foot infections may be able to decrease the use of mycobacterial cultures and health care costs because these infections are uncommon, according to study data.